Contrast-enhanced ultrasound in the assessment of Crohn’s disease activity: comparison with computed tomography enterography

Background and objective Continuous assessment of disease activity remains a huge challenge during the follow-ups of patients with Crohn’s disease (CD). In this paper, we aimed to evaluate the performance of contrast-enhanced ultrasound (CEUS) by comparing with computed tomography enterography (CTE) in the assessment of disease activity in CD. Materials and methods Fifty-two patients diagnosed with CD were included in this study, using the CEUS and CTE as imaging methods for comparison. The selected parameters included the location and thickness of the thickest part of the intestinal wall, mesenteric fat proliferation, mesenteric vessels change, enhancement pattern and the presence of complications. Patients were clinically assessed using the Crohn's disease activity index (CDAI), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Simple endoscopic score for Crohn’s disease (SES-CD) was regarded as the reference standard. Results The location of the thickest part of the intestinal wall ( κ = 0.653), bowel wall thickness (ICC = 0.795), mesenteric vessels change ( κ = 0.692) and complications ( κ = 0.796) displayed substantial agreement (0.61–0.80) between CEUS and CTE, while the detection of mesenteric fat proliferation ( κ = 0.395) and enhancement pattern ( κ = 0.288) showed fair consistency (0.21–0.40) for comparison. In CEUS, bowel wall thickness, mesenteric fat proliferation, enhancement pattern and mesenteric vessels change were statistically significant in assessing CD activity, while bowel wall thickness, mesenteric fat proliferation and mesenteric vessels change in CTE. Bowel wall thickness showed the best diagnostic performance in the assessment of CD activity at CEUS and CTE. Conclusion CEUS provides a radiation-free and effective way to assess the CD activity in comparison with CTE, which also avoids frequent colonoscopy examinations, improves tolerance of patients, and reduces the cost of medical care, thereby serving as a useful tool for CD follow-up.